Jyothy Labs Limited (IN:JYOTHYLAB)
:JYOTHYLAB
Want to see IN:JYOTHYLAB full AI Analyst Report?
Top Page
Jyothy Labs Limited
(JYOTHYLAB)
Select Model
Select Model
Rating:72Outperform
Price Target:
₹264.00
▼(-4.49% Downside)
Action:Reiterated
Date:05/12/26
The score is primarily supported by strong financial quality (very low leverage and solid profitability with positive free cash flow), partially offset by recent margin compression and weaker earnings in 2026. Technicals are mixed with price below key longer-term averages despite moderately positive momentum, and valuation appears middle-of-the-road (P/E ~21.7; yield ~1.47%).
Positive Factors
Conservative balance sheet
Very low leverage and consistently strong returns on equity (mid-teens to ~20%+) provide durable financial resilience. Low debt limits refinancing and interest risks, allowing management to fund marketing, distribution and capex from internal sources and preserve strategic optionality.
Negative Factors
Margin compression in 2026
Compression across gross, operating and net margins suggests structural pressure from input costs, pricing mix, or higher trade spend. If sustained, lower margins will reduce cash generation and returns, forcing either higher prices or cost restructuring to restore profitability.
Read all positive and negative factors
Positive Factors
Negative Factors
Conservative balance sheet
Very low leverage and consistently strong returns on equity (mid-teens to ~20%+) provide durable financial resilience. Low debt limits refinancing and interest risks, allowing management to fund marketing, distribution and capex from internal sources and preserve strategic optionality.
Read all positive factors
Jyothy Labs Limited (JYOTHYLAB) vs. iShares MSCI India ETF (INDA)
Market Cap
₹76.71B
Dividend Yield1.24%
Average Volume (3M)26.54K
Price to Earnings (P/E)21.7
Beta (1Y)1.07
Revenue Growth3.42%
EPS Growth-10.04%
CountryIN
Employees2,943
SectorConsumer Defensive
Sector Strength42
IndustryHousehold & Personal Products
Share Statistics
EPS (TTM)9.49
Shares Outstanding367,214,500
10 Day Avg. Volume19,687
30 Day Avg. Volume26,541
Financial Highlights & Ratios
PEG Ratio-2.15
Price to Book (P/B)4.56
Price to Sales (P/S)2.46
P/FCF Ratio20.24
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)9.93
Revenue Forecast (FY)₹32.42B
Jyothy Labs Limited Business Overview & Revenue Model
Company Description
Jyothy Labs Limited, together with its subsidiaries, engages in manufacturing and marketing fabric care, dishwashing, personal care, and household insecticides products in India and internationally. The company operates through Dishwashing, Fabric...
How the Company Makes Money
Jyothy Labs primarily makes money by manufacturing (in-house and/or through third-party manufacturing) and selling branded FMCG products to distributors/wholesalers and retail channels, with revenue recognized from product sales across its key cat...
Jyothy Labs Limited Financial Statement Overview
Summary
Income Statement
72
Positive
Balance Sheet
86
Very Positive
Cash Flow
74
Positive
| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 28.80B | 29.44B | 28.68B | 27.61B | 24.86B | 21.97B |
| Gross Profit | 14.04B | 9.80B | 14.39B | 13.48B | 10.42B | 9.06B |
| EBITDA | 4.97B | 4.50B | 5.05B | 4.74B | 3.08B | 2.39B |
| Net Income | 3.48B | 3.33B | 3.70B | 3.69B | 2.40B | 1.62B |
Balance Sheet | ||||||
| Total Assets | 21.22B | 22.52B | 26.91B | 24.01B | 20.62B | 20.23B |
| Cash, Cash Equivalents and Short-Term Investments | 8.05B | 8.16B | 5.99B | 6.16B | 2.81B | 2.09B |
| Total Debt | 537.40M | 515.80M | 612.80M | 505.60M | 465.30M | 1.71B |
| Total Liabilities | 6.84B | 6.64B | 6.41B | 5.91B | 5.11B | 6.20B |
| Stockholders Equity | 14.38B | 15.89B | 20.50B | 18.08B | 15.49B | 14.44B |
Cash Flow | ||||||
| Free Cash Flow | 1.61B | 3.58B | 2.53B | 4.21B | 2.93B | 1.77B |
| Operating Cash Flow | 1.96B | 4.25B | 3.11B | 4.58B | 3.29B | 2.03B |
| Investing Cash Flow | -1.17B | -2.94B | -1.61B | -3.44B | -482.90M | -317.13M |
| Financing Cash Flow | -1.44B | -1.55B | -1.57B | -1.35B | -2.51B | -1.67B |
Jyothy Labs Limited Technical Analysis
Negative
276.40
Price Trends
232.24
Negative
245.35
Negative
281.13
Negative
Market Momentum
-5.09
Positive
32.19
Neutral
2.26
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:JYOTHYLAB, the sentiment is Negative. The current price of 276.4 is above the 20-day moving average (MA) of 247.88, above the 50-day MA of 232.24, and below the 200-day MA of 281.13, indicating a bearish trend. The MACD of -5.09 indicates Positive momentum. The RSI at 32.19 is Neutral, neither overbought nor oversold. The STOCH value of 2.26 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for IN:JYOTHYLAB.
Jyothy Labs Limited Peers Comparison
UnderperformOutperform
Sector (62)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
75 Outperform | ₹799.58B | 38.40 | ― | 1.62% | 5.01% | 7.14% | |
75 Outperform | ₹1.09T | 54.03 | ― | 1.42% | 25.67% | 8.14% | |
73 Outperform | ₹5.19T | 40.36 | ― | 1.84% | 3.84% | 41.22% | |
72 Outperform | ₹76.71B | 21.75 | ― | 1.24% | 3.42% | -10.04% | |
65 Neutral | ₹313.25B | 38.08 | ― | 2.08% | -0.44% | 1.84% | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
59 Neutral | ₹1.05T | 54.14 | ― | 1.67% | 7.81% | 0.51% |
* Consumer Defensive Sector Average
IN:JYOTHYLAB
Jyothy Labs Limited
208.90
-126.58
-37.73%
IN:DABUR
Dabur India Limited
450.80
-23.76
-5.01%
IN:GODREJCP
Godrej Consumer Products Limited
1,022.90
-234.31
-18.64%
IN:HINDUNILVR
Hindustan Unilever Limited
2,209.05
-75.45
-3.30%
IN:MARICO
Marico Limited
838.90
136.16
19.38%
IN:PGHH
Procter & Gamble Hygiene & Health Care Ltd.
9,650.20
-4,206.26
-30.36%
Jyothy Labs Limited Corporate Events
Jyothy Labs Publishes FY26 Earnings Call Transcript for Investors
May 7, 2026
Jyothy Labs Limited has released the transcript of its earnings conference call for analysts and investors covering the quarter and full year ended March 31, 2026. The call, held on May 4, 2026, featured Chairperson and Managing Director M. R. Jyo...
Jyothy Labs Clears FY26 Results, Proposes Dividend and Sets Virtual AGM for July
May 4, 2026
Jyothy Labs Limited’s board has approved the audited financial results for the quarter and year ended March 31, 2026, with the statutory auditors issuing an unmodified opinion, underscoring the integrity of the company’s reported perfo...
Jyothy Labs Shuts Trading Window Ahead of FY26 Results
Mar 26, 2026
Jyothy Labs Limited has announced the closure of its trading window for designated persons and their immediate relatives starting April 1, 2026, in line with SEBI’s Prohibition of Insider Trading Regulations and its internal code of conduct....
Jyothy Labs Plans Routine One-on-One Meeting With Mirabilis Investment Trust
Mar 10, 2026
Jyothy Labs Limited has scheduled an investor and analyst meeting with Mirabilis Investment Trust on March 12, 2026, to be held as a one-on-one interaction. The company has clarified that no unpublished price-sensitive information will be shared d...
Jyothy Labs Schedules Investor Meeting With Eternity Capital
Mar 10, 2026
Jyothy Labs Limited has notified stock exchanges about a scheduled investor and analyst meeting with Eternity Capital on March 11, 2026. The company clarified that the interaction will not involve sharing any unpublished price-sensitive informatio...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.